1. Matsuda M, Shimizu T, Oouchi H, Saito S, Kawade M, Arakaki Y, et al. Diagnosis of myocardial ischemia using body surface electrocardiographic mapping with intravenous dipyridamole in children who have a history of Kawasaki disease [in Japanese]. J Jpn Pediatr Soc. 1995;99:1618–27.
2. Takechi N, Seki T, Ohkubo T, Ogawa S. Dobutamine stress surface mapping of myocardial ischemia in Kawasaki disease. Pediatr Int. 2001;43(3):218–25. http://dx.doi.org/10.1046/j.1442-200x.2001.01384.x PMID:11380912.
3. Takeuchi M, Matsushita A, Tsuda E, Kurotobi S, Kogaki S. Clinical assessment of ventricular late potential in children with Kawasaki disease: frequency analysis and its clinical significance [in Japanese]. Prog Med. 1994;14:1828–32.
4. Ogawa S, Nagai Y, Zhang J, Yuge K, Hino Y, Jimbo O, et al. Evaluation of myocardial ischemia and infarction by signal-averaged electrocardiographic late potentials in children with Kawasaki disease. Am J Cardiol. 1996;78(2):175–81. http://dx.doi.org/10.1016/S0002-9149(96)90392-6 PMID:8712139.
5. Genma Y, Ogawa S, Zhang J, Yamamoto M. Evaluation of myocardial ischemia in Kawasaki disease by dobutamine stress signal-averaged ventricular late potentials. Cardiovasc Res. 1997;36(3):323–9. http://dx.doi.org/10.1016/S0008-6363(97)00196-X PMID:9534852.